3-Me-PCPy

3-Me-PCPy: Research Chemical Overview, Structure, and Legality

3-Me-PCPy (3-Methyl-PCPy) is a dissociative compound belonging to the arylcyclohexylamine family. It is a structural analog of PCPy (1-Phenylcyclohexylpyrrolidine), with a methyl group added to the phenyl ring. This modification places 3-Me-PCPy within a class of substances studied for their NMDA receptor antagonist properties.

Although closely related to PCP derivatives, 3-Me-PCPy has unique characteristics that make it of scientific interest in neuropharmacological and receptor-binding research.

⚠️ This compound is not intended for human consumption and is supplied exclusively for laboratory use by qualified professionals.

---

Chemical Structure and Properties

3-Me-PCPy is a methylated analog of PCPy (also known as PHP or PCPy), featuring a pyrrolidine ring in place of the typical piperidine ring found in PCP. The methyl substitution at the 3-position of the phenyl ring may alter its receptor affinity and dissociative effects in in vitro systems.

• IUPAC Name: 1-[1-(3-methylphenyl)cyclohexyl]pyrrolidine

• Molecular Formula: C17H25N

• Chemical Class: Arylcyclohexylamine, dissociative anesthetic

• Physical Form: White or off-white crystalline powder

• Common Applications: In vitro research, receptor binding studies, SAR modeling

Researchers may find interest in the compound’s interaction with NMDA receptors, and potentially sigma receptors, although no clinical data currently exists.

---

Reported Effects (Informational Only)

There is limited formal research on the pharmacology of 3-Me-PCPy, but anecdotal reports suggest it produces effects similar to other dissociatives in the arylcyclohexylamine class.

Reported effects (from non-clinical environments) may include:

• Dissociative states and depersonalization

• Sensory detachment and altered perception

• Reduced motor coordination

• Introspection and cognitive disruption

• Potential stimulant-like activity in low ranges

These effects are speculative and derived from informal sources. 3-Me-PCPy has not been studied in human or animal clinical settings and should never be used outside of controlled laboratory environments.

---

Safety and Laboratory Handling

Due to a lack of comprehensive toxicological data, 3-Me-PCPy must be treated with extreme care. It may pose unknown health risks and should only be used in qualified laboratory facilities.

Essential safety practices include:

• Use of gloves, goggles, and lab coats (PPE)

• Use within a chemical fume hood

• Secure, labeled storage in a cool, dry place

• Avoiding inhalation, ingestion, or dermal exposure

Dispose of all waste materials according to institutional hazardous waste protocols.

---

Legal Status of 3-Me-PCPy

As of now, 3-Me-PCPy is not specifically scheduled in many jurisdictions but may be subject to control under analog legislation or psychoactive substance laws depending on regional interpretation.

• United States: Not scheduled at the federal level but may be regulated under the Federal Analog Act due to its structural similarity to PCP derivatives

• United Kingdom: May fall under the Psychoactive Substances Act (PSA)

• Germany: Potentially restricted under the NpSG (New Psychoactive Substances Act)

• Canada, Australia: Could be regulated as an analog or a structural isomer

• European Union: Regulation may vary by member state

Always confirm your local laws before purchasing or working with this compound.

---

For Research Use Only

3-Me-PCPy is strictly for scientific, forensic, or analytical research. It is not approved for use in humans or animals and must be handled only by licensed or accredited laboratories. All usage must comply with local, national, and international regulations.